chr7-45888981-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000596.4(IGFBP1):​c.329C>A​(p.Ala110Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

IGFBP1
NM_000596.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0240
Variant links:
Genes affected
IGFBP1 (HGNC:5469): (insulin like growth factor binding protein 1) This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP N-terminal domain and a thyroglobulin type-I domain. The encoded protein, mainly expressed in the liver, circulates in the plasma and binds both insulin-like growth factors (IGFs) I and II, prolonging their half-lives and altering their interaction with cell surface receptors. This protein is important in cell migration and metabolism. Low levels of this protein may be associated with impaired glucose tolerance, vascular disease and hypertension in human patients. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04921785).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IGFBP1NM_000596.4 linkuse as main transcriptc.329C>A p.Ala110Asp missense_variant 1/4 ENST00000275525.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IGFBP1ENST00000275525.8 linkuse as main transcriptc.329C>A p.Ala110Asp missense_variant 1/41 NM_000596.4 P4
IGFBP1ENST00000457280.5 linkuse as main transcriptc.329C>A p.Ala110Asp missense_variant 1/45 A2
IGFBP1ENST00000468955.1 linkuse as main transcriptc.329C>A p.Ala110Asp missense_variant 1/35

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1366080
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
674574
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 27, 2023The c.329C>A (p.A110D) alteration is located in exon 1 (coding exon 1) of the IGFBP1 gene. This alteration results from a C to A substitution at nucleotide position 329, causing the alanine (A) at amino acid position 110 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
7.6
DANN
Benign
0.74
DEOGEN2
Benign
0.16
T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.39
T;T;T
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.049
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.063
Sift
Benign
0.57
T;T;T
Sift4G
Benign
0.64
T;T;T
Polyphen
0.0020
B;B;B
Vest4
0.052
MutPred
0.17
Loss of glycosylation at S108 (P = 0.0952);Loss of glycosylation at S108 (P = 0.0952);Loss of glycosylation at S108 (P = 0.0952);
MVP
0.46
MPC
0.51
ClinPred
0.047
T
GERP RS
-6.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.091
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-45928580; API